EyePoint Investor Alert
[ad_1] Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options New York, New York–(Newsfile Corp. – November 18, 2022) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against EyePoint Pharmaceuticals (“Eyepoint” or the “Company”) […]
Centessa Deadline Alert
[ad_1] Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Centessa To Contact Him Directly To Discuss Their Options New York, New York–(Newsfile Corp. – November 18, 2022) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Centessa Pharmaceuticals plc. (“Centessa” or the […]
Dendritic Cell Therapy Market Analysis – Industry Specific
The latest published industry study on the “Market for Dendritic Cell Therapy” provides an overview of the current global dendritic cell therapy market dynamics and how our survey participants, all outsourcing decision makers, predict the market in 2030. The research report contains everything you need to know about the industry. It offers market insights by […]
Market research for anticoagulation and dual platelet aggregation inhibitors
Anticoagulant and Dual Antiplatelet Drugs Market Report Overview and Forecast 2022-2030: “SMI” Research has published a report on this Anticoagulation and Dual Antiplatelet Market such that the overall market dynamics and analysis are well represented by the various segments such as product type, application, end-user, regions, and market dominant players. The study highlights regional and […]
Acadia Trofinetide Phase III – Positive top-line clinical results
On 12/06/2021, US time, Acadia Pharmaceuticals (Nasdaq: ACAD) announced positive top-line results from its Phase III clinical trial of its drug candidate Trofinetide. The phase III study, called Lavender, will be used primarily to evaluate the safety and effectiveness of trofinetide in treating Rett Syndrome (RS). A total of 189 subjects were enrolled, all females […]
INVESTIGATION OF SHAREHOLDERS: Halper Sadeh LLC is being investigated
NEW YORK, Nov. 15, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of federal securities laws and/or violations of shareholder fiduciary duties with respect to: Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT). Sale to Individual PLC. Under the terms of the agreement, Indivior would acquire Opiant […]
Bronstein, Gewirtz & Grossman, LLC, a top firm, announces
NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is notifying investors that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (“Centessa” or the “Company”) ( NASDAQ: CNTA) and certain of its officers on behalf of all persons and entities that have purchased or otherwise […]
Benign prostatic hyperplasia (BPH) prostate treatment market is increasing
Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Key Insights During the forecast period 2023-2033, the global market for prostate treatments for benign prostatic hyperplasia (BPH). is expected to reach an estimated value of ~USD 13.0 billion by 2033 by expanding at a CAGR of ~6%. The market generated ~$7.0 billion in additional revenue in […]
INVESTIGATION OF SHAREHOLDERS: Halper Sadeh LLC is being investigated
NEW YORK, Nov. 13, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of federal securities laws and/or violations of shareholder fiduciary duties related to: by Metacrine Inc. (NASDAQ: MTCR). Merged with Equillium, Inc. If you are a Metacrine shareholder, Click here to learn […]
Metabolomics market to expand at ~13% CAGR
Key insights into the global Metabolomics market During the forecast period 2023-2033, the global Metabolomics Market is expected to reach an estimated value of ~$5 billion by 2033 by expanding at a CAGR of ~13%. The market will also generate revenue of ~$2 billion in 2022. Increasing acceptance of metabolomics in precision medicine as well […]
Bragar Eagle & Squire, PC reminds investors of this class
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits may be filed on behalf of shareholders of Warner Bros. Discovery, Inc. ( NASDAQ: WBD ), Olo, Inc. (NYSE: OLO), Centessa Pharmaceuticals Plc (NASDAQ: CNTA) and PayPal Holdings, […]
Bragar Eagle & Squire, PC examines EyePoint, F45,
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), F45 Training Holdings, Inc (NYSE : FXLV), PROG Holdings, Inc. (NYSE: PRG) and Intuit, Inc. (NASDAQ: INTU). Our investigations address whether these companies have violated […]